Do you have or are you a patient with Hyperemesis Gravidarum?
You or they may be eligible for inclusion in a new study that UKTIS are currently involved in.
The EMPOWER (EMesis in Pregnancy – Ondansetron With mEtoclopRamide) study, funded by the NIHR, aims to determine the best treatment of Hypermesis Gravidarum.
It will also investigate the impact on participant’s quality of life and carry out a health economic analysis.
For more information please visit the EMPOWER website here
Twitter: @EmpowerStudy Facebook: The Empower Study
Pregnancy summaries - New for Feb 2019
when downloading these pregnancy summaries you will be redirected to our sister site www.medicinesinpregnancy.org
How to report medication exposure in pregnancy
Report your own pregnancy by creating your own ‘my bumps’ pregnancy record here
Healthcare professionals can report all pregnancy exposures to UKTIS here
Accessing UKTIS pregnancy information
UKTIS abstracts are openly available here Full scientific reviews for healthcare professionals are available via www.toxbase.org BUMPS - Patient information leaflets available here.
News and Events
Human teratogens education course and 3rd International Joint Meeting of the ENTIS and OTIS
Photograph courtesy of Visit England
Thank you to all our speakers and delegates who made the UK’s first Human Teratogens Education Course and the 3rd Internation Joint Meeting of the European Network of Teratology Information Services (ENTIS) and Organization of Teratology Information Specialists (OTIS) such a success.
Delegates from around the globe were treated to presentations from some of the most influential researchers and clinicians in the field.
Free online access to the conference abstracts, published in a special edition of Reproductive Toxicology (September Volume 80) along with proceedings from the 2018 ETS meeting , will be available via the Science Direct website for one year.
We look forward to seeing you at 2019 ENTIS conference in Oslo.